Jazz Pharmaceuticals (JAZZ) Other financing activities (2012 - 2016)

Jazz Pharmaceuticals has reported Other financing activities for 5 years, with the latest figure at -$3.5 million in Q3 2016.

• For the quarter ending Q3 2016, Other financing activities fell 994.69% year-over-year to -$3.5 million; the trailing twelve-month figure through Sep 2016 stood at $320000.0 (up 112.53% YoY), and the FY2014 full-year result was $1.8 million, changed N/A from the prior year.
• Other financing activities for Q3 2016 stood at -$3.5 million, up from -$4.4 million in the prior quarter.
• The five-year high for Other financing activities was $10.6 million in Q1 2015, with the low at -$10.6 million in Q2 2015.
• Average Other financing activities over 5 years is $741000.0, with a median of $320000.0 recorded in 2015.
• Year-over-year, Other financing activities jumped 3903.66% in 2014 and slumped 994.69% in 2016.
• Tracing JAZZ's Other financing activities over 5 years: stood at $5.5 million in 2012, then slumped by 98.51% to $82000.0 in 2013, then slumped by 2824.39% to -$2.2 million in 2014, then jumped by 114.32% to $320000.0 in 2015, then sank by 1194.69% to -$3.5 million in 2016.
• The last three Other financing activities figures came in at -$3.5 million (Q3 2016), -$4.4 million (Q2 2016), and $7.9 million (Q1 2016), per Business Quant data.

Peer Comparison